ArticlePilot and feasibility studies2023

An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).

Carina Joy Donegan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.